tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
AVBP
ArriVent BioPharma, Inc.
RESEARCH TOOLSreports
Want to see AVBP full AI Analyst Report?

ArriVent BioPharma, Inc. (AVBP) Cash flow

80 Followers

ArriVent BioPharma, Inc. Cash Flow

AVBP's free cash flow for Q4 2025 was $-30.66M. For the 2025 fiscal year, AVBP's free cash flow was decreased by $-90.38M and operating cash flow was $-30.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Investing Cash Flow
$ -71.23M$ -192.47M$ 0.00$ 0.00$ -40.00M
Financing Cash Flow
$ 203.06M$ 186.58M$ 42.86M$ 169.72M$ 89.87M
End Cash Position
$ 45.54M$ 74.29M$ 150.39M$ 163.37M$ 37.28M
Free Cash Flow
$ -160.59M$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Currency in USD

ArriVent BioPharma, Inc. Cash Flow